Matthew Shields
Evp, Global Operations at Teva Pharmaceutical Industries Ltd (TEVA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.4M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 22SEC | TEVATeva Pharmaceutical Industries Ltd | Sell | 9,989 | $32.19 | $322K | +28.9% |
| Jun 4SEC | TEVATeva Pharmaceutical Industries Ltd | Sell Plan | 16,1959,989 held (−62%) | $32.87 | $532K | +26.3% |
| Mar 9SEC | TEVATeva Pharmaceutical Industries Ltd | Sell Plan | 17,2959,989 held (−63%) | $31.67 | $548K | +31.0% |
- Sell
Evp, Global Operations Matthew Shields sold $532K of TEVA at $32.87 — cuts the stake by 62%; pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Global Operations Matthew Shields sold $548K of TEVA at $31.67 — cuts the stake by 63%; pre-scheduled 10b5-1 plan sale.